Benzocyclo[1,2]oxaborol-1(3H)-ol derivatives as SHP2 inhibitors, compositions and methods thereof

By developing novel phosphine oxide compounds as SHP2 inhibitors, the problems of insufficient safety and efficacy in existing technologies have been solved, enabling the application of these compounds in drug development. These compounds exhibit good pharmacokinetic properties and therapeutic effects.

CN122295347APending Publication Date: 2026-06-26CANWELL BIOTECH LTD
View PDF 25 Cites 0 Cited by

Patent Information

Application Number
CN202480075985.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-10-16
Filing Date
2024-10-09
Publication Date
2026-06-26

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This invention provides a novel phosphine oxide compound that inhibits SHP2, a composition thereof, a method for preparing the compound, and a method for treating SHP2-related diseases (such as cancer).
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Novel aryloxyphenylpropanamines

    WO2007005643A2

  • Novel aryloxypropanamines

    WO2007005644A2

  • Novel pharmaceutical compounds

    WO2007016361A2

  • Novel benzo [d] [1,3]-dioxol derivatives

    WO2007016431A2

  • 1 -pyridazin- / triazin-3-YL-piper(-azine) / idine / pyrolidine derivatives and and compositions thereof for inhibiting the activity of SHP2

    WO2015107493A1